Diffusion Pharmaceuticals Inc. Gains 34.02%
Mon, Jan 11, 2021 at 05:30 PM
Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ) rocketted at $1.3, representing a gain of 34%. The stock got featured on our News Catalysts scanner on Mon 11 Jan 21 at 10:07 AM in the 'MISCELLANEOUS' category. From Mon 28 Dec 20, the stock recorded 50.00% Up Days and 44.44% Green Days
The stock spiked on Tue 21 Jul 20 at $1.6 with a volume of 10M+.
About Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ)
Diffusion Pharmaceuticals Inc is a clinical stage biotechnology company focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy.
Top 10 Gainers:
- Zomedica Pharmaceuticals Corp. (ZOM:NYSEMKT), 92.15%
- Sify Technologies Limited (SIFY:NASDAQ), 79.25%
- Avinger, Inc. (AVGR:NASDAQ), 61.9%
- TransEnterix, Inc. (TRXC:NYSEMKT), 43.1%
- Aileron Therapeutics, Inc. (ALRN:NASDAQ), 42.22%
- IsoRay, Inc. (ISR:NYSEMKT), 39.29%
- JUPW (JUPW:NASDAQ), 36.46%
- China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), 34.43%
- Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ), 34.02%
- Ekso Bionics Holdings, Inc. (EKSO:NASDAQ), 32.95%